Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats

BACKGROUND: Mangiferin (MNG) is known to possess antidiabetic and antioxidant activity. However, there is no experimental evidence presently available in the literature with regard to its ameliorating effects on diabetes mellitus coexisting with metabolic syndrome. OBJECTIVE: The present study was d...

Descripción completa

Detalles Bibliográficos
Autores principales: Suman, Rajesh Kumar, Mohanty, Ipseeta Ray, Maheshwari, Ujwala, Borde, Manjusha K, Deshmukh, YA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010077/
https://www.ncbi.nlm.nih.gov/pubmed/27621658
http://dx.doi.org/10.2147/DMSO.S109599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010077/
https://www.ncbi.nlm.nih.gov/pubmed/27621658
http://dx.doi.org/10.2147/DMSO.S109599

Ejemplares similares